Replies to post #4879 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

What would be more consequential than the Fast Track designation is Priority Review, which shortens the FDA review period from 10 months to 6 months. GTC can ask for Priority Review when the final module of the BLA is submitted in 1Q08.